1-20 of 1016
alkylating agents
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Follow-up of Idelalisib Monotherapy in Patients with Double-Refractory Marginal Zone Lymphoma or Lymphoplasmacytic Lymphoma/ Waldenstrom's Macroglobulinemia

Nina D. Wagner-Johnston, MD, Stephen J. Schuster, MD, Sven de Vos, MD PhD, Gilles A. Salles, MD PhD, Wojciech Jurczak, MD PhD, Nishan Rajakumaraswamy, MD, Guan Xing, PhD, Ajay K. Gopal, MD
Blood (2019) 134 (Supplement_1): 4006.
DOI: https://doi.org/10.1182/blood-2019-121936
Published: 2019
Journal Articles

A Phase 2 Study of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Antibody (Ab), in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)

Max S. Topp, MD, Johannes Duell, MD, Jingjin Li, PhD, Vladimir Jankovic, MD, Israel Lowy, MD PhD, David Sternberg, MD PhD, Lieve Adriaens, PharmD, Mary Peterman, PharmD, Srikanth R. Ambati, MBBS, MD, Rajat Bannerji, MD PhD
Blood (2019) 134 (Supplement_1): 4007.
DOI: https://doi.org/10.1182/blood-2019-126670
Published: 2019
Journal Articles

A Randomized Phase 2 Study Comparing Acalabrutinib with or without Obinutuzumab in the Treatment of Early Stage High Risk Patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Sameer A. Parikh, MD, Eli Muchtar, MD, Betsy Laplant, MS, Wei Ding, MD PhD, Sikander Ailawadhi, MD, Amber Koehler, PA-C, MS, Timothy G. Call, MD, Saad S. Kenderian, MD, Jose F. Leis, MD PhD, Amie Fonder, PA-C, MS, Min Shi, MD PhD, Asher A. Chanan-Khan, MD, Adam Pettinger, Thomas E. Witzig, MD, Carrie A. Thompson, MD, Jose C Villasboas, Jessica M Sholes, Curtis A. Hanson, MD, Esteban Braggio, PhD, Kay L. Medina, PhD, Susan L. Slager, PhD, Neil E. Kay, MD
Blood (2019) 134 (Supplement_1): 4306.
DOI: https://doi.org/10.1182/blood-2019-123824
Published: 2019
Journal Articles

Full Donor Chimerism after Allografts for Myelofibrosis: The Role of Conditioning Regimen

Patrizia Chiusolo, Sabrina Giammarco, MD PhD, Teresa Lamparelli, Lucia Casarino, Monica Rossi, Alida Dominietto, MD, Anna Maria Raiola, MD, Francesca Gualandi, Carmen Di Grazia, MD, Silvia Betti, MD PhD, Federica Sorà, MD, Elena Rossi, MD PhD, Luciana Teofili, MD, Simona Sica, MD, Andrea Bacigalupo, MD, Emanuele Angelucci, MD
Blood (2019) 134 (Supplement_1): 4490.
DOI: https://doi.org/10.1182/blood-2019-126711
Published: 2019
Journal Articles

Similar Survival with Deferred Versus Salvage Autologous Stem Cell Transplant in Light Chain Amyloidosis

Danny Luan, BS, MPH, Koen Van Besien, MD PhD, Paul J Christos, Dr.P.H., M.S., Roger Pearse, MD PhD, Danielle Guarneri, BS, CCRP, Morton Coleman, MD, Ruben Niesvizky, MD, Cara A. Rosenbaum, MD
Blood (2019) 134 (Supplement_1): 4579.
DOI: https://doi.org/10.1182/blood-2019-127723
Published: 2019
Journal Articles

Patterns of Relapse and Treatment for Relapsed/Refractory AL Amyloidosis: A Systematic Review

Adeela Mushtaq, MD, Hamza Hassan, MD MBBS, Razwana Khanam, MD, Ahmad Iftikhar, MD, Midhat Lakhani, MD, Muhammad Abdullah Yousaf, MBBS, MD, Muhaddis Ejaz Ahmad, MD, Maaz Ahmed Yusufi, MD, Seemal Iftikhar, MD, Aneeqa A Zafar, MD, Irbaz Riaz, MDMMSc, M Hasib Sidiqi, MBBS, Faiz Anwer, MD
Blood (2019) 134 (Supplement_1): 5556.
DOI: https://doi.org/10.1182/blood-2019-125148
Published: 2019
Journal Articles

Therapy-Related Myeloid Neoplasms Following Treatment for Multiple Myeloma : A Single-Center Analysis

Amelie Boquoi, MD, Soraya Magdalena Banahan, MD, Judith Strapatsas, MD, David Lopez y Niedenhoff, MD, Guido Kobbe, MD, Norbert Gattermann, MD, Ulrich Germing, MD, Rainer Haas, MD, Thomas Schroeder, MD, Roland Fenk, MD
Blood (2019) 134 (Supplement_1): 4261.
DOI: https://doi.org/10.1182/blood-2019-122598
Published: 2019
Journal Articles

Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL): Long Term Outcomes and Secondary Malignancies in 673 Patients Treated in British Columbia (BC)

Elysha Vanderveer, MD BSc, Steven J.T. Huang, BMLSc, Helene Bruyere, MD FCCMG, Tanya Gillan, PhD FCCMG, Charles H. Li, MDFRCPC, Khaled Ramadan, MBBCH, MRCP, FRCPath, Diego Villa, MD MPH, David W. Scott, MBChB, PhD, Kerry J Savage, BSc, MD MSc, Joseph M Connors, MD, Laurie H Sehn, MD, Cynthia L Toze, MD FRCPC, Alina S Gerrie, MD MPH
Blood (2019) 134 (Supplement_1): 4300.
DOI: https://doi.org/10.1182/blood-2019-125189
Published: 2019
Journal Articles

Risk Factors for Progression to Blast Phase and Outcome in 589 Patients with Myelofibrosis Treated with Ruxolitinib: Real-World Evidence

Francesca Palandri, PhD MD, Massimo Breccia, MD, Mario Tiribelli, Nicola Polverelli, Giulia Benevolo, MD, Alessia Tieghi, MD, Gianni Binotto, MD, Massimiliano Bonifacio, MD, Bruno Martino, MD, Alessandra Iurlo, MD, Elena Maria Elli, MD, Elisabetta Abruzzese, MD, Micaela Bergamaschi, MD, Nicola Sgherza, MD, Francesco Cavazzini, MD, Monica Crugnola, MD, Costanza Bosi, MD, Alessandro Isidori, MD PhD, Florian H. Heidel, MD, Uros Markovic, MD, Giuseppe Auteri, MD, Lucia Catani, Roberto Latagliata, Davide Griguolo, MD, Katia Codeluppi, PhD, Daniele Cattaneo, MD, Malgorzata Monika Trawinska, MD, Daniela Bartoletti, MSc, Mauro Krampera, Gianpietro Semenzato, Roberto Massimo Lemoli, MD, Antonio Cuneo, MD, Michele Cavo, Nicola Vianelli, MD, Giuseppe A. Palumbo, MD PhD
Blood (2019) 134 (Supplement_1): 4166.
DOI: https://doi.org/10.1182/blood-2019-123379
Published: 2019
Journal Articles

Cost Effective Cardio Protective Intervention in Haploidentical Hematopoietic Stem Cell Transplantation in Children - a Study from a Tertiary Care Centre in India

Revathi Raj, Ramya Uppuluri, MD, Venkateswaran Vellaichamy, MD, Nikila Ravichandran, MD, Kesavan Melarkode Ramanan, MD
Blood (2019) 134 (Supplement_1): 5866.
DOI: https://doi.org/10.1182/blood-2019-131539
Published: 2019
Journal Articles

Results of a Phase I/II Study of Bendamustine in Combination with Ofatumumab, Carboplatin and Etoposide (BOCE) for Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphomas

Jonathan Pan, MD, Sushil Ghimire, MD, Tingting Zhan, PhD, Onder Alpdogan, MD, Andrew E. Chapman, DO, Matthew Carabasi, MD, Ubaldo Martinez-Outschoorn, MD, Lewis J. Rose, MD, Michael Ramirez, MD, John L Wagner, MD, Barbara Pro, MD, Mark A. Weiss, MD, Neal Flomenberg, MD, Pierluigi Porcu, MD, Joanne Filicko-O'Hara, MD, Sameh Gaballa, MD
Blood (2019) 134 (Supplement_1): 5318.
DOI: https://doi.org/10.1182/blood-2019-125836
Published: 2019
Journal Articles

ME-401-003 (TIDAL): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Phase 2 Study of ME-401 Investigating Continuous and Intermittent Dosing Schedules in Patients with Relapsed/Refractory Follicular Lymphoma

Andrew D. Zelenetz, MD PhD, Pier Luigi Luigi Zinzani, MD, Henry Chan, MBChB, Christian Buske, MD PhD, Vincent Ribrag, David Cunningham, MD FRCP, FMedSci, Wojciech Jurczak, Pau Abrisqueta, MD PhD, Joanne Li, Igor Gorbatchevsky, MD, Jennifer R. Brown, MD PhD
Blood (2019) 134 (Supplement_1): 5244.
DOI: https://doi.org/10.1182/blood-2019-124326
Published: 2019
Journal Articles

Randomized Phase 2 Zanubrutinib (BGB-3111) + Obinutuzumab Vs Obinutuzumab Monotherapy in Patients with Relapsed/Refractory Follicular Lymphoma (R/R FL)

Nathan H. Fowler, MD, Judith Trotman, MBChB, FRACP, FRCPA, Rebecca Auer, MRCP, FRPath, PhD, Christopher R. Flowers, MD MS, William F. Reed, MD, Elena Ivanova, PhD, Jane Huang, MD, Pier Luigi Zinzani, MD PhD
Blood (2019) 134 (Supplement_1): 5252.
DOI: https://doi.org/10.1182/blood-2019-122628
Published: 2019
Journal Articles

Racial Differences in High-Risk Cytogenetic Mutations and Outcomes in Multiple Myeloma

Ben A Derman, MDBA, Meytal Chernoff, BS, Andrzej Jakubowiak, MD PhD, Brian C.-H. Chiu, PhD
Blood (2019) 134 (Supplement_1): 5494.
DOI: https://doi.org/10.1182/blood-2019-126304
Published: 2019
Journal Articles

Carfilzomib Based Regimens for Treatment of Newly Diagnosed Multiple Myeloma: A Systematic Review

Maimoona Khan, MBBS, Asma Waheed, MBBS, Rida Ul Jannat, MBBS, Arafat Ali Ali Farooqui, MD, Muhammad Saad Farooqi, MD, Ali Younas Khan, MD, Madeeha Shafqat, Muhaddis Ejaz Ahmad, MD, Muhammad Abdullah Yousaf, MBBS, MD, Tariq Iqtidar Sadiq Syed, MD, Syed Maaz Abdullah, MBBS, Sravanthi Kotapati, MBBS, Irbaz Riaz, MDMMSc, Faiz Anwer, MD
Blood (2019) 134 (Supplement_1): 5588.
DOI: https://doi.org/10.1182/blood-2019-128833
Published: 2019
Journal Articles

Three Drug Regimens for Newly Diagnosed Multiple Myeloma Transplant-Ineligible Elderly Patients - a Systematic Review

Abdul Aziz Siddiqui, MD, Kazi Najamus-saqib Khan, Arafat Ali Farooqui, MD, Muhammad Saad Farooqi, MD, Muhammad Junaid Tariq, MD, Faiz Anwer, MD
Blood (2019) 134 (Supplement_1): 5574.
DOI: https://doi.org/10.1182/blood-2019-132095
Published: 2019
Journal Articles

Evolving Real-World Treatment Patterns in Patients with Newly-Diagnosed Multiple Myeloma (NDMM) in the United States (U.S.)

Sikander Ailawadhi, MD, Dorothy Romanus, RPh, PhD, Dasha Cherepanov, PhD, Yu Yin, MS, MA, Meng-Ru Cheng, MSPH, Parameswaran Hari, MBBS, MD
Blood (2019) 134 (Supplement_1): 3164.
DOI: https://doi.org/10.1182/blood-2019-124301
Published: 2019
Journal Articles

Impact of Different Doses of Fludarabine in Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow Transplantation

Kodai Kuriyama, MD PhD, Shigeo Fuji, MD PhD, Noriko Doki, MD PhD, Yuta Katayama, MD PhD, Souichi Shiratori, Yukiyasu Ozawa, MD PhD, Takashi Ashida, MD PhD, Junya Kanda, MD, Takahiro Fukuda, Yoshiko Atsuta, MD PhD, Masao Ogata, MD PhD
Blood (2019) 134 (Supplement_1): 3258.
DOI: https://doi.org/10.1182/blood-2019-123926
Published: 2019
Journal Articles

Inhibition of ATR Overcomes Chemotherapy Resistance in p53 Deficient Myeloma Cells

Louise Bouard, MDin training, Benoit Tessoulin, MD PhD, Géraldine Descamps, PhD, Cyrille Touzeau, MD PhD, Philippe Moreau, MD, Martine Amiot, PhD, Catherine Pellat-Deceunynck, PhD
Blood (2019) 134 (Supplement_1): 3109.
DOI: https://doi.org/10.1182/blood-2019-122547
Published: 2019
Journal Articles

Optimal Therapy for Relapsed AL Amyloidosis Post Autologous Stem Cell Transplant

M Hasib Sidiqi, MBBS, Abdullah S. S. Al Saleh, MBBS, Iuliana Vaxman, MDBA, Angela Dispenzieri, MD, Francis K. Buadi, MB, CHB, Eli Muchtar, MD, Rahma M Warsame, MD, Martha Q. Lacy, MD, David Dingli, MD PhD, Nelson Leung, MD, Wilson I Gonsalves, MD, Prashant Kapoor, MD, Taxiarchis Kourelis, MD, S. Vincent Rajkumar, MD, Shaji K. Kumar, MD, Morie A Gertz, MD
Blood (2019) 134 (Supplement_1): 3171.
DOI: https://doi.org/10.1182/blood-2019-125453
Published: 2019